Qualified institutional placements (QIPs) witnessed a resilient growth in July so far, led by State Bank of India’s (SBI) ...

SBIs RS25,000 crore QIP, oversubscribed 3×, has pushed India’s QIP fundraising to a 5-year high, reflecting strong ...

The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo Nordisk A/S’ Novolog (insulin aspart), a ...

Indian equity indices continued their downward trend for the second straight session on 18 July , with Nifty dropping below ...

Little surprise then that Citi was top of Dealogic’s Asia Pacific ex-Japan G3 DCM revenue league table in 2024, with $77 ...

The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable ...

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

Q2 2025 saw deal value drop 62% as large-ticket M&A dried up; investors pivot to focused platforms in pharma, hospitals, ...

Forbes’ 2025 list ranks Nykaa’s Falguni Nayar and Biocon’s Kiran Mazumdar-Shaw among the 50 wealthiest self-made women in the ...

State Bank of India (SBI), the largest lender in the country, has launched a share sale to institutional investors to raise ...

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.